These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10164135)

  • 1. How business is dealing with the AIDS epidemic.
    Gerson V
    Bus Health; 1997 Jan; 15(1):17-20. PubMed ID: 10164135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in HIV/AIDS care require hard choices.
    Lawrence J
    Manag Care; 1998 Oct; 7(10):39-43. PubMed ID: 10185863
    [No Abstract]   [Full Text] [Related]  

  • 3. Knowledge, attitudes, beliefs, and behaviors of the business community relative to HIV-AIDS.
    Farnham PG
    Public Health Rep; 1991; 106(6):663-6. PubMed ID: 1956975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and economic impact of new antiretroviral treatments].
    Moreno Guillén S; Pérez Elías MJ
    Rev Clin Esp; 1999 Feb; 199(2):53-4. PubMed ID: 10216393
    [No Abstract]   [Full Text] [Related]  

  • 5. Costs to business for an HIV-infected worker.
    Farnham PG; Gorsky RD
    Inquiry; 1994; 31(1):76-88. PubMed ID: 8168911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economic burden and clinical course of HIV infection and AIDS today: how the variation of natural history, available treatments, and strictly related costs play a role in needs of health care].
    Manfredi R; Calza L; Gramegna A; Bocchi F; Fiacchi P; Corsini D; Chiodo F
    Recenti Prog Med; 2001 Nov; 92(11):648-54. PubMed ID: 11765655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS is your business.
    Rosen S; Simon J; Vincent JR; MacLeod W; Fox M; Thea DM
    Harv Bus Rev; 2003 Feb; 81(2):80-7, 125. PubMed ID: 12577655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of delaying or preventing AIDS in persons with HIV.
    Pinkerton SD; Holtgrave DR
    Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Part D drug benefit and HIV/AIDS: questions and answers.
    Valenti WM
    AIDS Read; 2006 Feb; 16(2):66, 70-1. PubMed ID: 16471271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.
    Fleck F
    Bull World Health Organ; 2004 Jan; 82(1):77-8. PubMed ID: 15106303
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives. Need for access to new drugs creates big challenge for state ADAP programs (AIDS Drug Assistance Programs); better coordination with Medicaid urged.
    Cunningham R
    Med Health; 1999 Mar; 53(11):suppl 1-4. PubMed ID: 10346194
    [No Abstract]   [Full Text] [Related]  

  • 12. Self-Insured health care plans: are they fair to employees with HIV/AIDS?
    Cameron T
    J Health Soc Policy; 1998; 10(1):23-40. PubMed ID: 10180252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey search: four studies of employers' responses to AIDS.
    Health Cost Manage; 1986; 3(1):7-15, 18. PubMed ID: 10275858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A question of care. HMO officials and AIDS activists are divided over the quality of AIDS care.
    Mod Healthc; 1996 Jun; 26(26):122, 124, 126-9. PubMed ID: 10158322
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV/AIDS. The great funding surge.
    Cohen J
    Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
    [No Abstract]   [Full Text] [Related]  

  • 17. The health insurance jigsaw. How to line up an arrangement that will keep you covered.
    Thomas D
    Posit Aware; 1995; ():16-8, 21. PubMed ID: 11362206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of AIDS and HIV infection: the experience of a public hospital in the context of national forecasts.
    Rietmeijer CA
    Compr Ther; 1993; 19(4):174-6; quiz 177-81. PubMed ID: 7903233
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV/AIDS. Botswana's success comes at steep cost.
    Cohen J
    Science; 2008 Jul; 321(5888):526-9. PubMed ID: 18653882
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.